What oral medications are recommended for treating hair loss in men and women, including considerations for women of child‑bearing potential?

Oral Medications for Hair Loss

For men with androgenetic alopecia, start with oral finasteride 1 mg daily; for women, start with low-dose oral minoxidil 1.25 mg daily, but women of child-bearing potential must avoid finasteride entirely due to teratogenic risk.

Men with Hair Loss

First-Line: Finasteride

• Finasteride 1 mg daily is the established oral treatment for male pattern hair loss 1
• Blocks conversion of testosterone to DHT, the androgen driving male pattern baldness
• Clinical efficacy: 48% showed improvement at 1 year, 66% at 2 years on global photography 1
• 83% had no further hair loss at 2 years versus 28% with placebo 1

Key side effects to counsel about:

• Sexual dysfunction (decreased libido, erectile dysfunction, ejaculation disorders) occurs in 3.8% versus 2.1% placebo 1
• Most sexual side effects resolve with continued therapy or upon discontinuation 1

Alternative: Low-Dose Oral Minoxidil (LDOM)

• Start at 2.5 mg daily, can advance to 5 mg daily 2
• International consensus supports this as safe and effective off-label treatment 3
• Check blood pressure and pulse before first dose and 2 hours after to assess cardiovascular response 2

Women with Hair Loss

First-Line: Low-Dose Oral Minoxidil

The dosing algorithm for women is weight and cardiovascular-risk stratified 2:

Standard-risk women:

• Start 1.25 mg daily 2
• Can advance if tolerated

High-risk women (low weight, baseline low BP, or cardiovascular history):

• Start 0.5 mg (compounded) or 0.625 mg (¼ of 2.5 mg tablet) 2
• Remain on initial dose for several weeks to assess tolerability 2

Critical monitoring:

• Check BP and pulse before and 2 hours post-dose when starting 2
• Monitor for fluid retention (swelling, weight gain) at 2-4 months 2
• Expect dose-dependent facial/body hair growth (hypertrichosis) by 2-4 months 2

Finasteride in Women: Strict Contraindications

Finasteride is absolutely contraindicated in women of child-bearing potential due to risk of hypospadias in male fetuses 1.

If used in premenopausal women, it MUST be combined with effective contraception:

• One study used finasteride 2.5 mg daily with drospirenone/ethinyl estradiol oral contraceptive 4
• 62% showed improvement, though unclear if due to higher finasteride dose or the antiandrogenic effect of drospirenone 4
• This remains off-label and requires rigorous contraceptive compliance

Common Pitfalls to Avoid

With oral minoxidil:

• Don't ignore cardiovascular history—tachycardia can precipitate angina 2
• Beta blockers may block reflex tachycardia but potentiate hypotensive effects 2
• Any unwanted BP decrease may last days 2
• Stop immediately if chest pain or shortness of breath develops and seek emergency care 2
• Transient shedding at 4-6 weeks is expected and positive, not a reason to discontinue 2

With finasteride:

• Never prescribe to pregnant women or those not using reliable contraception 1
• Counsel men that sexual side effects, while uncommon, are the main concern 1

Practical Implementation

For men: Finasteride 1 mg daily remains the evidence-based standard. Consider LDOM 2.5-5 mg daily if finasteride fails or is not tolerated 3, 2.

For women of child-bearing age: LDOM starting at 1.25 mg daily (or 0.5-0.625 mg if high-risk) is the safest option 2. Finasteride is contraindicated unless combined with highly effective contraception 4, 1.

For postmenopausal women: Both LDOM and finasteride can be considered, though LDOM has stronger recent consensus support 3, 2.